Abstract
Hypertensive disorders in pregnancy pose a huge challenge to the socioeconomic stability of a community; being a major cause of maternal and neonatal morbidity and mortality during delivery. Although there have been recent improvements in management strategies, still, the diversified nature of the underlying pathogenesis undermines their effectiveness. Generally, these disorders are categorized into two; hypertensive disorders of pregnancy with proteinuria (pre-eclampsia and eclampsia) and hypertensive disorders of pregnancy without proteinuria (gestational and chronic hypertension). Each of these conditions may present with unique characteristics that have interwoven symptoms. However, the tendency of occurrence heightens in the presence of any pre-existing life-threatening condition(s), environmental, and/or other genetic factors. Investigations into the cerebrovascular system demonstrate changes in the histoarchitectural organization of neurons, the proliferation of glial cells with an associated increase in inflammatory cytokines. These are oxidative stress indicators which impose a deteriorating impact on the structures that form the neurovascular unit and the blood-brain barrier (BBB). Such a pathologic state distorts the homeostatic supply of blood into the brain, and enhances the permeability of toxins/pathogens through a process called hyperperfusion at the BBB. Furthermore, a notable aspect of the pathogenesis of hypertensive disorders of pregnancy is endothelial dysfunction aggravated when signaling of the vasoprotective molecule, nitric oxide, amongst other neurotransmitter regulatory activities are impaired. This review aims to discuss the alterations in cerebrovascular regulation that determine the incidence of hypertension in pregnancy.
Similar content being viewed by others
Data availability
Not applicable.
References
Abalos E et al (2014) Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health . BJOG Int J Obstet Gynaecol 121:14–24
ACOG (2019) ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol 133:e1–e25. https://doi.org/10.1097/aog.0000000000003018
Armulik A et al (2010) Pericytes regulate the blood–brain barrier. Nature 468:557–561
Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ (2011) Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011:214365
Baggio MRF, Martins WP, Calderon ACS, Berezowski AT, Marcolin AC, Duarte G, Cavalli RC (2011) Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. Ultrasound Med Biol 37:53–58
Bateman BT et al (2015) Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol 212:337.e331-337.e314
Belfort MA, Tooke-Miller C, Allen JC Jr, Varner MA, Grunewald C, Nisell H, Herd JA (2001) Pregnant women with chronic hypertension and superimposed pre-eclampsia have high cerebral perfusion pressure. Br J Obstet Gynaecol 108:1141–1147
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2019) Heart disease and stroke Statistics-2019: update a report from the American Heart Association. Circulation 139:e56–e528
Berhe AK, Kassa GM, Fekadu GA, Muche AA (2018) Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy Childbirth 18:1–11
Bernardi F, Constantino L, Machado R, Petronilho F, Dal-Pizzol F (2008) Plasma nitric oxide, endothelin‐1, arginase and superoxide dismutase in pre‐eclamptic women. J Obstet Gynaecol Res 34:957–963
Bowen RS, Zhang Y, Gu Y, Lewis DF, Wang Y (2005) Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta 26:402–409
Brown MA et al (2018) Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 72:24–43
Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a. systematic review Hypertension 60:444–450
Bureau UA (2012) Three successful Sub-Saharan Africa family planning programs: Ethiopia, Malawi, Rwanda. USAID, Washington, DC
Chen Q et al (2012) Calcium channel blockers prevent endothelial cell activation in response to necrotic trophoblast debris: possible relevance to pre-eclampsia. Cardiovasc Res 96:484–493
Cingolani HE et al (2006) The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension 47:727–734
Cipolla MJ (2013) The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences. J Cereb Blood Flow Metab 33:465–478
Cipolla MJ, Sweet JG, Chan S-L (2011) Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol 110:329–339
Cipolla MJ, Bishop N, Chan S-L (2012) Effect of pregnancy on autoregulation of cerebral blood flow in anterior versus posterior cerebrum. Hypertension 60:705–711
Collange O, Launoy A, Kopf-Pottecher A, Dietemann J-L, Pottecher T (2010) Eclampsie. Annales francaises d’anesthesie et de reanimation, vol 4. Elsevier, Amsterdam, pp e75–e82
Cooper WO et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451
Csiszar A et al (2017) Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease. Geroscience 39:359–372
Cunningham F, Leveno K, Bloom S, Hauth J, Rouse D, Spong C (2010) Pregnancy hypertension. In: Cunningham F, Leveno K, Bloom S, Dashe J,Hoffman B, Casey B, Spong C (eds) Williams obstetrics. 23 edn. McGraw-Hill, New York, pp 706–756
Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2008) Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 39:349–354
Dayan N, Kaur A, Elharram M, Rossi AM, Pilote L (2018) Impact of preeclampsia on long-term cognitive function. Hypertension 72:1374–1380
De Silva TM, Faraci F (2013) Effects of angiotensin II on the cerebral circulation: role of oxidative stress. Front Physiol 3:484
Diav-Citrin O et al (2011) Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol 31:540–545
Eiríksdóttir VH et al (2015) Pregnancy-induced hypertensive disorders before and after a national economic collapse: a population based cohort study. PLoS One 10:e0138534
Euser AG, Cipolla MJ (2007) Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 49:334–340
Fan Y, Yang X, Tao Y, Lan L, Zheng L, Sun J (2015) Tight junction disruption of blood–brain barrier in white matter lesions in chronic hypertensive rats. Neuroreport 26:1039–1043
Faraco G et al (2016b) Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Investig 126:4674–4689
Faraco G, Iadecola C (2013) Hypertension: a harbinger of stroke and dementia. Hypertension 62:810–817
Faraco G, Park L, Zhou P, Luo W, Paul SM, Anrather J, Iadecola C (2016) Hypertension enhances A β-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP. J Cereb Blood Flow Metab 36:241–252
Garovic VD et al (2020) Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol 75:2323–2334
Gilbert JS, Gilbert SA, Arany M, Granger JP (2009) Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53:399–403
Girouard H, Iadecola C (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100:328–335
Groenhof TKJ et al (2019) Trajectory of cardiovascular risk factors after hypertensive disorders of pregnancy: an argument for follow-up. Hypertension 73:171–178
Gu Y, Lewis DF, Wang Y (2008) Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 93:260–266
Gudeta TA, Regassa TM (2019) Pregnancy induced hypertension and associated factors among women attending delivery service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest. Ethiopia. Ethiop J Health Sci 29(1):831–840
Habli M, Sibai BM (2008) Hypertension in pregnancy. Therapy in nephrology & hypertension. Elsevier, Amsterdam, pp 479–485
Halliday MR, Pomara N, Sagare AP, Mack WJ, Frangione B, Zlokovic BV (2013) Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. JAMA Neurol 70:1198–1200
Hammer ES, Cipolla MJ (2015) Cerebrovascular dysfunction in preeclamptic pregnancies. Curr Hypertens Rep 17:64
Haram K, Mortensen JH, Myking O, Magann EF, Morrison JC (2019) The role of oxidative stress, adhesion molecules and antioxidants in preeclampsia. Curr Hypertens Rev 15:105–112
Hofmeyr GJ, Belfort M (2009) Proteinuria as a predictor of complications of pre-eclampsia. BMC Med 7:1–3
Iadecola C (2014) Hypertension and dementia. Hypertension 64:3–5
Iadecola C, Gottesman RF (2019) Neurovascular and cognitive dysfunction in hypertension: epidemiology, pathobiology, and treatment. Circ Res 124:1025–1044
Ijomone OK, Shallie P, Naicker T (2018) Changes in the structure and function of the brain years after pre-eclampsia. Ageing Res Rev 47:49–54
Ijomone OK, Shallie PD, Naicker T (2019) N-nitro-L-arginine methyl model of pre-eclampsia elicits differential IBA1 and EAAT1 expressions in brain. J Chem Neuroanat 100:101660
Jaatinen N, Ekholm E (2016) Eclampsia in Finland; 2006 to 2010. Acta Obstet Gynecol Scand 95:787–792
Johnson AC, Nagle KJ, Tremble SM, Cipolla MJ (2015) The contribution of normal pregnancy to eclampsia. PLoS One 10:e0133953
Johnson AC, Hammer ES, Sakkaki S, Tremble SM, Holmes GL, Cipolla MJ (2018) Inhibition of blood-brain barrier efflux transporters promotes seizure in pregnant rats: Role of circulating factors . Brain Behav Immun 67:13–23
Jones-Muhammad M, Warrington JP (2019) Cerebral blood flow regulation in pregnancy, hypertension, and hypertensive disorders of pregnancy. Brain Sci 9:224
Karumanchi SA (2018) Pregnancy and the kidney. Textbook of Nephro-Endocrinology. Elsevier, Amsterdam, pp 319–345
Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP (2005) Preeclampsia: a renal perspective. Kidney Int 67:2101–2113
Kassebaum NJ et al (2014) Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:980–1004
Khan K et al (2010) Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis. J Matern Fetal Neonatal Med 23:1030–1038
Kim T, Richard Jennings J, Kim S-G (2014) Regional cerebral blood flow and arterial blood volume and their reactivity to hypercapnia in hypertensive and normotensive rats. J Cereb Blood Flow Metab 34:408–414
Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V (2015) Pregnancy-induced hypertension. Hormones 14:211–223
Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017) Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci 18:419
Kleinrouweler CE et al (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis . BJOG Int J Obstet Gynaecol 119:778–787
LaMarca B et al (2009) Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54:905–909
Lee RM, Dickhout JG, Sandow SL (2017) Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance. Hypertens Res 40:311–323
Leeners B, Neumaier-Wagner P, Kuse S, Stiller R, Rath W (2007) Emotional stress and the risk to develop hypertensive diseases in pregnancy. Hypertens Pregnancy 26:211–226
Li X, Han X, Yang J, Bao J, Di X, Zhang G, Liu H (2017) Magnesium sulfate provides neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema. Mol Neurobiol 54:7938–7948
Lozano R et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128
Magee L et al (2016) Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial . BJOG Int J Obstet Gynaecol 123:1143–1151
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy . Pregnancy Hypertens 4:105–145
Malvasi A, Tinelli A, Di Renzo GC (2017) Management and therapy of late pregnancy complications: third trimester and puerperium. Springer, Berlin
Marshall SA, Leo CH, Girling JE, Tare M, Beard S, Hannan NJ, Parry LJ (2017) Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction. Biol Reprod 96:895–906
Masson C, Levardon M (1990) Eclampsia. Presse Med (Paris, France: 1983) 19:1188
Michinaga S, Koyama Y (2015) Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci 16:9949–9975
Miller EC (2019) Preeclampsia and cerebrovascular disease: the maternal brain at risk. Hypertension 74:5–13
Miller KB, Miller VM, Barnes JN (2019) Pregnancy history, hypertension, and cognitive impairment in postmenopausal women. Curr Hypertens Rep 21:93
Mogi M (2019) Could management of blood pressure prevent dementia in the elderly? Clin Hypertens 25:27
Morikawa M, Yamada T, Yamada T, Cho K, Sato S, Minakami H (2014) Seasonal variation in the prevalence of pregnancy-induced hypertension in Japanese women. J Obstet Gynaecol Res 40:926–931
Mtali YS, Lyimo MA, Luzzatto L, Massawe SN (2019) Hypertensive disorders of pregnancy are associated with an inflammatory state: evidence from hematological findings and cytokine levels. BMC Pregnancy Childbirth 19:237. doi:https://doi.org/10.1186/s12884-019-2383-7
Mustafa R, Ahmed S, Gupta A, Venuto RC (2012) A comprehensive review of hypertension in pregnancy. J Pregnancy 2012:105918
Nadruz W (2015) Myocardial remodeling in hypertension. J Hum Hypertens 29:1–6
Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M (2003) Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res 93:523–530
Nobili F et al (1993) Regional cerebral blood flow in chronic hypertension. A correlative study. Stroke 24:1148–1153
Osol G, Mandala M (2009) Maternal uterine vascular remodeling during pregnancy. Physiology 24:58–71
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH (2017) Chronic hypertension and adverse pregnancy outcome: a cohort study . Ultrasound Obstet Gynecol 50:228–235
Panaitescu AM, Roberge S, Nicolaides KH (2019) Chronic hypertension: effect of blood pressure control on pregnancy outcome. J Matern Fetal Neonatal Med 32:857–863
Petersen KM et al (2012) β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open 2(4):e001185
Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142–160
Rocca WA et al (2018) Loss of ovarian hormones and accelerated somatic and mental aging. Physiology 33:374–383
Salomon A, Ishaku S, Kirk KR, Warren CE (2019) Detecting and managing hypertensive disorders in pregnancy: a cross-sectional analysis of the quality of antenatal care in Nigeria. BMC Health Serv Res 19:411
Setiadi A, Korim WS, Elsaafien K, Yao ST (2018) The role of the blood–brain barrier in hypertension. Exp Physiol 103:337–342
Shabir O, Berwick J, Francis SE (2018) Neurovascular dysfunction in vascular dementia Alzheimer’s atherosclerosis. BMC Neurosci 19:62
Shah S (2020) Hypertensive disorders in pregnancy. In: Obstetric and gynecologic nephrology. Springer, Berlin, pp 11–23
Sharma C, Soni A, Gupta A, Verma A, Verma S (2017) Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. Am J Obstet Gynecol 217:687.e681-687.e686
Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192
Sica DA (2015) Centrally acting antihypertensive agents in the treatment of hypertension. Pathophysiology and pharmacotherapy of cardiovascular disease. Springer, Berlin, pp 853–868
Sierra C (2014) Essential hypertension, cerebral white matter pathology and ischemic stroke. Curr Med Chem 21:2156–2164
Soma-Pillay P, Catherine N-P, Tolppanen H, Mebazaa A, Tolppanen H, Mebazaa A (2016) Physiological changes in pregnancy . Cardiovascular J Afr 27:89
Stennett AK, Khalil RA (2006) Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res 3:131–148
Stuart JJ et al (2013) Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Women’s Health 22:37–47
Suzuki H et al (2017) Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension. PLoS One 12:e0187600
Takeuchi S, Nagatani K, Otani N, Nawashiro H, Sugawara T, Wada K, Mori K (2015) Hydrogen improves neurological function through attenuation of blood–brain barrier disruption in spontaneously hypertensive stroke-prone rats. BMC Neurosci 16:1–13
Tenório MB, Ferreira RC, Moura FA, Bueno NB, de Oliveira ACM, Goulart MOF (2019) Cross-Talk between Oxidative Stress and Inflammation inPreeclampsia Oxidative medicine and cellular longevity 2019:8238727
Torres-Vergara P, Escudero C, Penny J (2018) Drug transport at the brain and endothelial dysfunction in preeclampsia: implications and perspectives. Front Physiol 9:1502
Ukah UV et al (2018) Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertension 11:115–123
Umans JG (2007) Hypertension in pregnancy. Comprehensive hypertension. Elsevier, Amsterdam, pp 669–680
van Assema DM et al (2012) P-glycoprotein function at the blood–brain barrier: effects of age and gender . Mol Imaging Biol 14:771–776
van Veen TR, Panerai RB, Haeri S, Griffioen AC, Zeeman GG, Belfort MA (2013) Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol 122:1064–1069
Verburg PE, Tucker G, Scheil W, Erwich JJH, Roberts CT, Dekker GA (2015) [177-POS]: Seasonality of pregnancy induced hypertensive disorders in South Australia–A retrospective population study 2007–2011 . Pregnancy Hypertens 5:91
Vezzani A, Balosso S, Ravizza T (2008) The role of cytokines in the pathophysiology of epilepsy . Brain Behav Immun 22:797–803
von Dadelszen P, Magee LA (2016) Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 36:83–102
Wang N, Mi X, Gao B, Gu J, Wang W, Zhang Y, Wang X (2015) Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neuroscience 287:144–156
Wenger NK et al (2018) Hypertension across a woman’s life cycle. J Am Coll Cardiol 71:1797–1813
Yamamoto T, Suzuki Y, Kojima K, Suzumori K (2005) Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia. Am J Obstet Gynecol 192:558–563
Younes ST, Ryan MJ (2019) Pathophysiology of cerebral vascular dysfunction in pregnancy-induced hypertension. Curr Hypertens Rep 21:52
Zeng Z, Liu F, Li S (2017) Metabolic adaptations in pregnancy: a review . Ann Nutr Metab 70:59–65
Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201
Acknowledgements
O.M.I. acknowledges the support of the International Brain Research Organization (IBRO) to The Neuro- Lab, School of Health and Health Technology, Federal University of Technology Akure, Nigeria.
Author information
Authors and Affiliations
Contributions
Conception – O.K.I. and O.M.I.; Manuscript writing – O.K.I., I.R.O., COAO; Critical review – G.T.A., O.M.I. All authors approved final manuscript draft.
Corresponding authors
Ethics declarations
Ethical approval
Not applicable. This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ijomone, O.K., Osahon, I.R., Okoh, C.O.A. et al. Neurovascular dysfunctions in hypertensive disorders of pregnancy. Metab Brain Dis 36, 1109–1117 (2021). https://doi.org/10.1007/s11011-021-00710-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00710-x